California’s Stem Cell Agency awarded $56 million for clinical research, $21.3 million for Shared Labs program
On Feb. 23, 2024, the California Institute for Regenerative Medicine (CIRM) awarded $56 million to fund various clinical…
On Feb. 23, 2024, the California Institute for Regenerative Medicine (CIRM) awarded $56 million to fund various clinical…
On Feb. 22, 2024, the University of California, San Francisco (UC, San Francisco) launched the world’s first tissue…
On Feb. 22, 2024, a National Institutes of Health (NIH) research supported project announced development of a tool…
On Feb. 21, 2024, the National Institutes of Health (NIH) announced it had launched a clinical trials network…
On Feb. 21, 2024, the Fred Hutchinson Cancer Center announced it was at the helm of a new…
On Feb. 21, 2024, the U.S. Department of Agriculture (USDA) and the University of Georgia (UGA) College of…
On Feb. 21, 2023, the Cancer Prevention and Research Institute of Texas (CPRIT) announced it had approved $98,592,155…
On Feb. 21, 2024, the World Health Organization reported that more than half the world’s countries will be…
On Feb. 20, 2024, the U.S. Department of Agriculture (USDA) confirmed the presence of highly pathogenic avian influenza…
On Feb. 19, 2024, the National Institutes of Health (NIH) announced that researchers had discovered more than 275…
On Feb. 16. 2024, Roche announced today that the U.S. Food and Drug Administration (FDA) has approved Xolair…
On Feb. 16, 2024, Regeneron and Sanofi announced that the Ministry of Health, Labor and Welfare (MHLW) in…
On Feb. 16, 2024, the U.S. Centers for Disease Control and Prevention announced that ten people infected with…
On Feb. 16, 2024, the Australian Government announced it had issued QUT a licence to commercially release QCAV-4,…
On Feb. 15, 2024, Biosecurity experts today launched a new international nonprofit designed to prevent modern biotechnology from…
On Feb. 14, 2024, the U.S. Food and Drug Administration approved Eicos Sciences’ Aurlumyn (iloprost) injection to treat…
On Feb. 14, 2024, the National Institute of Allergy and Infectious Diseases (NIAID) reported study results that showed…
On Feb. 13, 2024, CRISPR Therapeutics announced that the European Commission had granted conditional marketing authorization to CASGEVY…
On Feb. 12, 2024, the U.S. Centers for Disease Control and Prevention (CDC) announced that Cambodia had reported…
On Feb. 9, 2024, the state of Alaska Department of Health Alaska Department of Health confirmed the first…
On Feb. 8, 2024, Deschutes County Health Services confirmed a case of human plague in a local resident….
On Feb. 8, 2024, the National Science Foundation (NSF) announced it was investing $9.75 million to advance novel…
On Feb. 6, 2024, the U.S. Department of Agriculture (USDA) announced it was investing over $70 million in…
On Feb. 6, 2024, Oregon Health & Science University (OHSU) announced research that revealed as much as a…
On Feb. 5, 2024, CSL and and Arcturus Therapeutics announced the results of a follow-up analysis of a…
On Feb. 5, 2024, a U.S. Centers for Disease Control and Prevention (CDC) celebrated the opening of the…
On Feb. 2, 2024, Chinese scientists announced they have assembled the world’s most detailed human genome yet, a…
On Feb. 1, 2024, the World Health Organization (WHO) announced that new estimates on IARCï¾’s Global Cancer Observatory…
On Jan. 31, 2024, a U.S. Centers for Disease Control and Prevention (CDC) co-authored study published in Influenza…
On Jan. 31, 2024, researchers at the National Institutes of Health detected abnormal proteins in the spinal fluid…